05:17 PM EDT, 07/15/2025 (MT Newswires) -- John Cox, Director, CEO & President, on July 14, 2025, executed a purchase for 100,000 shares in Dyne Therapeutics ( DYN ) for $911,000. Following the Form 4 filing with the SEC, Cox has control over a total of 314,179 common shares of the company, with 242,179 shares held directly and 72,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1818794/000095017025095929/xslF345X05/ownership.xml